Certolizumab Pegol for the Treatment of Moderate to Severe Plaque Psoriasis: 16-Week Results from a Phase 2/3 Japanese Study
media
posted on 2021-02-17, 10:56 authored by Adis journals on behalf of, Yoshinori Umezawa, Shinya Sakurai, Naoki Hoshii, Hidemi Nakagawa<p><strong>Article full
text</strong></p>
<p><br></p><p>
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.<b>
</b></p>
History
Related Materials
- 1.
- 2.
